These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34564989)

  • 1. FBXL19-AS1 aggravates the progression of hepatocellular cancer by downregulating KLF2.
    Chen Y; Yang L
    J BUON; 2021; 26(4):1333-1339. PubMed ID: 34564989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA AFAP1-AS1 promotes proliferation and migration of gastric cancer by downregulating KLF2.
    Yuan XH; Li J; Cao Y; Jie ZG; Zeng YF
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):673-680. PubMed ID: 32016968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2.
    Guo Y; Bai M; Lin L; Huang J; An Y; Liang L; Liu Y; Huang W
    Biomed Pharmacother; 2019 Oct; 118():109272. PubMed ID: 31376657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA FOXP4-AS1 facilitates the biological functions of hepatocellular carcinoma cells via downregulating ZC3H12D by mediating H3K27me3 through recruitment of EZH2.
    Ye J; Fu Y; Wang Z; Yu J
    Cell Biol Toxicol; 2022 Dec; 38(6):1047-1062. PubMed ID: 34545456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00702 accelerates the progression of ovarian cancer through interacting with EZH2 to inhibit the transcription of KLF2.
    Wang L; Ye TY; Wu H; Chen SY; Weng JR; Xi XW
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):201-208. PubMed ID: 31389610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
    Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
    Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBXL19-AS1 promotes cell proliferation and inhibits cell apoptosis via miR-876-5p/FOXM1 axis in breast cancer.
    Dong G; Pan T; Zhou D; Li C; Liu J; Zhang J
    Acta Biochim Biophys Sin (Shanghai); 2019 Nov; 51(11):1106-1113. PubMed ID: 31696201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated lncRNA CACNA1G-AS1 aggravates the progression of colorectal cancer by downregulating p53.
    Wei LJ; Bai DM; Wang ZY; Liu BC
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):130-136. PubMed ID: 31957825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of ZEB2-AS1 inhibits cell invasion and induces apoptosis in colorectal cancer.
    Wu X; Zhu H; Xie Y; Gu X; Zhang L; Huang L
    J BUON; 2020; 25(1):194-201. PubMed ID: 32277632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway.
    Wan T; Zheng J; Yao R; Yang S; Zheng W; Zhou P
    Ann Hepatol; 2021; 20():100258. PubMed ID: 32961346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA FBXL19-AS1 induces tumor growth and metastasis by sponging miR-203a-3p in lung adenocarcinoma.
    Wang L; Zhang X; Liu Y; Xu S
    J Cell Physiol; 2020 Apr; 235(4):3612-3625. PubMed ID: 31566718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC00202 attenuates the progression of gastric cancer via suppressing expression level of KLF2.
    Xu Q; Qiao S; Liu L; Xu J; Yang L; Chen X; Yang L; Yao B
    J BUON; 2021; 26(2):506-512. PubMed ID: 34076999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21.
    Wei C; Wang H; Xu F; Liu Z; Jiang R
    Biomed Pharmacother; 2018 Aug; 104():137-144. PubMed ID: 29772433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA FOXC2-AS1 stimulates proliferation of melanoma via silencing p15 by recruiting EZH2.
    Xu DF; Tao XH; Yu Y; Teng Y; Huang YM; Ma JW; Fan YB
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8940-8946. PubMed ID: 32964984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
    Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.